Supporting the $1000 Genome
February 9, 2012
February 10, 2012 | With the $1,000 genomic sequencing barrier looming, the question remains whether we'll be able to make sense of the data to come pouring off sequencers like Life Technologies' new Ion Proton Sequencer. Colin Hill, CEO of GNS Healthcare argues that the infrastructure is ready in this commentary. Forbes
